Lead Product(s) : Follitropin
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Anixa Biosciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
Details : Follicle Stimulating Hormone is a Hormone drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Ovarian Neoplasms.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
April 07, 2022
Lead Product(s) : Follitropin
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Anixa Biosciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Follitropin
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Merck Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Step Down FSH Approach and Late Follicular Phase in Progesterone Level
Details : Follicle Stimulating Hormone is a Hormone drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
November 29, 2017
Lead Product(s) : Follitropin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Merck Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Follitropin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Fertility Laboratories Of Colorado
Deal Size : Inapplicable
Deal Type : Inapplicable
In Vitro Maturation of Human Eggs
Details : Follicle Stimulating Hormone is a Hormone drug candidate, which is currently being evaluated in clinical studies for the treatment of Infertility.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
August 06, 2015
Lead Product(s) : Follitropin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Fertility Laboratories Of Colorado
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Follitropin
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Immunogenicity of Repeated Follicle Stimulating Hormone (FSH) Stimulation Cycles
Details : Follicle Stimulating Hormone is a Hormone drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
February 07, 2013
Lead Product(s) : Follitropin
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Follitropin
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Merck Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Follicle Stimulating Hormone is a Hormone drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
February 19, 2010
Lead Product(s) : Follitropin
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Merck Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
